[go: up one dir, main page]

NO20050279D0 - Ny fremgangsmate - Google Patents

Ny fremgangsmate

Info

Publication number
NO20050279D0
NO20050279D0 NO20050279A NO20050279A NO20050279D0 NO 20050279 D0 NO20050279 D0 NO 20050279D0 NO 20050279 A NO20050279 A NO 20050279A NO 20050279 A NO20050279 A NO 20050279A NO 20050279 D0 NO20050279 D0 NO 20050279D0
Authority
NO
Norway
Prior art keywords
compounds
preparation
serotonin
prophylaxis
new procedure
Prior art date
Application number
NO20050279A
Other languages
English (en)
Inventor
Magnus Cernerud
Helena Lundstrom
Claes Lofstrom
Margit Pelckman
Tom Fleck
Alexander Paptchikhine
Emma Andersson
Alf Nygren
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0201881A external-priority patent/SE0201881D0/xx
Priority claimed from SE0202041A external-priority patent/SE0202041D0/xx
Priority claimed from SE0202516A external-priority patent/SE0202516D0/xx
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Publication of NO20050279D0 publication Critical patent/NO20050279D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Pyridine Compounds (AREA)

Abstract

Det beskrives en fremgangsmåte for fremstilling av forbindelser som er terapeutisk aktive i sentralnervesystemet. I et aspekt beskrives det en fremgangsmåte for fremstilling av forbindelser med den generelle formel (I). Oppfinnelsen angår også (2R)- 1-(3 -klor-2-pyrazinyl)-2-metylpiperazin, hydroklorid og en fremgangsmåte for fremstilling derav. Videre beskrives en forbindelse med formel (I). Forbindelsene som oppnås under anvendelse ved behandling eller profylakse av serotoninrelaterte lidelser og videre beskrives bruken av forbindelsene for fremstilling av medikamenter for profylakse eller terapi av serotoninrelaterte lidelser.
NO20050279A 2002-06-19 2005-01-18 Ny fremgangsmate NO20050279D0 (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
SE0201881A SE0201881D0 (sv) 2002-06-19 2002-06-19 Novel compounds, their use, and preparation
US39065602P 2002-06-21 2002-06-21
SE0202041A SE0202041D0 (sv) 2002-06-28 2002-06-28 Novel process
US40611902P 2002-08-26 2002-08-26
SE0202516A SE0202516D0 (sv) 2002-08-26 2002-08-26 Novel compounds, their use, and preparation
US41670102P 2002-10-07 2002-10-07
PCT/SE2003/001043 WO2004000829A1 (en) 2002-06-19 2003-06-18 Novel process

Publications (1)

Publication Number Publication Date
NO20050279D0 true NO20050279D0 (no) 2005-01-18

Family

ID=30004077

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050279A NO20050279D0 (no) 2002-06-19 2005-01-18 Ny fremgangsmate

Country Status (16)

Country Link
EP (2) EP1529043B1 (no)
JP (4) JP4592417B2 (no)
CN (1) CN100334082C (no)
AT (2) ATE334980T1 (no)
AU (1) AU2003237746B8 (no)
CA (1) CA2485532C (no)
CY (1) CY1106225T1 (no)
DE (2) DE60307286T2 (no)
DK (2) DK1645558T3 (no)
ES (2) ES2307102T3 (no)
HK (1) HK1080079B (no)
NO (1) NO20050279D0 (no)
NZ (1) NZ536663A (no)
PT (2) PT1645558E (no)
SI (2) SI1529043T1 (no)
WO (1) WO2004000829A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006022420A1 (ja) 2004-08-25 2006-03-02 Takeda Pharmaceutical Company Limited 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
MX2010004232A (es) 2007-10-16 2010-09-30 Daiichi Sankyo Co Ltd Compuesto de indolina de pirimidilo.
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
CA2765239C (en) 2009-06-15 2018-08-07 Takeda Pharmaceutical Company Limited Pyrazinooxazepine derivatives
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
GB201304811D0 (en) * 2013-03-15 2013-05-01 Proximagen Ltd Novel treatment for hypertension
EP3733204A4 (en) 2017-12-27 2021-09-15 Takeda Pharmaceutical Company Limited THERAPEUTIC AGENT FOR URINARY INCONTINENCE OF STRESS AND FECAL INCONTINENCE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06306075A (ja) * 1993-04-23 1994-11-01 Sanwa Kagaku Kenkyusho Co Ltd エトキシベンズアミド誘導体
DE60024986T2 (de) * 1999-05-21 2006-07-27 Biovitrum Ab Pyrazinyl-piperazin-verbindungen, ihre anwendung und herstellung
AR032318A1 (es) * 2000-04-13 2003-11-05 Pharmacia Corp Compuesto derivado halogenado del acido 2-amino-5,6 heptenoico; composicion farmaceutica que lo comprende y su uso en la fabricacion de un medicamento util como inhibidor de la oxido nitrico sintetasa
ES2328671T3 (es) * 2000-11-20 2009-11-17 Biovitrum Ab (Publ) Compuestos de piperazilpirazinas como antagonistas del receptor de serotonina 5-ht2.

Also Published As

Publication number Publication date
HK1080079B (zh) 2008-03-14
AU2003237746B8 (en) 2010-01-28
PT1645558E (pt) 2008-07-30
CA2485532A1 (en) 2003-12-31
DE60307286T2 (de) 2007-10-25
CN100334082C (zh) 2007-08-29
HK1080079A1 (zh) 2006-04-21
DE60307286D1 (de) 2006-09-14
JP2005537316A (ja) 2005-12-08
ES2270051T3 (es) 2007-04-01
DK1645558T3 (da) 2008-10-06
CY1106225T1 (el) 2011-06-08
EP1529043A1 (en) 2005-05-11
PT1529043E (pt) 2006-12-29
EP1645558B1 (en) 2008-06-11
JP2013227336A (ja) 2013-11-07
CN1662523A (zh) 2005-08-31
NZ536663A (en) 2007-05-31
WO2004000829A1 (en) 2003-12-31
AU2003237746B2 (en) 2009-12-17
JP5378241B2 (ja) 2013-12-25
ATE398119T1 (de) 2008-07-15
SI1645558T1 (sl) 2008-10-31
CA2485532C (en) 2012-03-06
AU2003237746A1 (en) 2004-01-06
EP1645558A1 (en) 2006-04-12
ES2307102T3 (es) 2008-11-16
ATE334980T1 (de) 2006-08-15
DE60321606D1 (de) 2008-07-24
JP2010120949A (ja) 2010-06-03
EP1529043B1 (en) 2006-08-02
JP2013116906A (ja) 2013-06-13
DK1529043T3 (da) 2006-12-04
SI1529043T1 (sl) 2006-12-31
JP4592417B2 (ja) 2010-12-01

Similar Documents

Publication Publication Date Title
BR0310106A (pt) Composto, processo para a produção de um composto, composição farmacêutica, uso do composto e método para o tratamento de um sujeito em sofrimento de uma condição ou doença patalógica
NO20093464L (no) Nye medikamentblandinger basert pa anti-cholinergisk effektive forbindelser og beta-mimetika
SE0100568D0 (sv) Compounds
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
ATE369353T1 (de) Medizinisch verwendbare arylethanolamin verbindungen
NO20051962L (no) Fenetanolaminderivater for behandling av respiratoriske sykdommer
MXPA04005209A (es) Antagonistas del receptor de adenosina a2a.
NO20062884L (no) AKT-proteinkinaseinhibitorer
IL173062A0 (en) Substituted 2-aminotetralin for the treatment of depression
SE0100569D0 (sv) New compounds
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
SE0104331D0 (sv) Novel compounds
ATE342264T1 (de) Indolderivate und deren verwendung als gnrh antagonisten
NO20060020L (no) 3-fluorpiperidiner som NMDA/NR2B-antagonister
BR9910899A (pt) Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida
NO20050279D0 (no) Ny fremgangsmate
SE9903894D0 (sv) Novel compounds
NO330888B1 (no) Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom
NO20052698L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application